TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma.

Hyun-Sung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.